The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Will Be The Estimated Market Size Of The Post-Marketing Pharmacovigilance And Medical Information Market By 2030?
The market size for post-marketing pharmacovigilance and medical information has expanded rapidly in recent years. It is anticipated to grow from $6.9 billion in 2025 to $7.71 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. The historical growth can be attributed to elements such as limited post-marketing surveillance infrastructure, reliance on manual ADR reporting, increasing regulatory requirements for drug safety, a greater number of new drug approvals, and a lack of integrated hospital data systems.
The post-marketing pharmacovigilance and medical information market size is anticipated to undergo rapid expansion in the coming years. It is projected to reach $11.89 billion in 2030, at a compound annual growth rate (CAGR) of 11.4%. This growth during the forecast period can be attributed to the integration of AI and ML algorithms into signal detection, the adoption of longitudinal patient data analysis, the broadening of disease registry-linked monitoring, an increase in digital app-based reporting, and rising investments in real-time pharmacovigilance technologies. Key trends for the forecast period include the increasing embrace of electronic health record (EHR) mining, a growing utilization of real-time adverse drug reaction (ADR) monitoring systems, an expansion in risk population-based and therapeutic class-based reporting, the extension of cohort event monitoring for new drug users, and the incorporation of digital and mobile platforms for pharmacovigilance reporting.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27393&type=smp
What Core Drivers Are Transforming The Post-Marketing Pharmacovigilance And Medical Information Market?
An increasing occurrence of adverse drug reactions is projected to drive expansion in the post-marketing pharmacovigilance and medical information market. These reactions are defined as undesirable or detrimental effects that manifest when a drug is administered at its prescribed dose for preventive, diagnostic, or therapeutic reasons. The frequency of adverse drug reactions is escalating because the elderly demographic increasingly needs remedies for various long-term illnesses, resulting in the concurrent use of multiple drugs, which elevates the potential for detrimental interactions and unforeseen adverse events. The post-marketing pharmacovigilance and medical information sector aids in managing adverse drug reactions through identifying, monitoring, and disseminating information about potential side effects once a drug has been introduced to the market, thereby assisting in preserving its safety and efficacy. As an illustration, data from January 2023, provided by Navikenz, a US-based IT services firm specializing in artificial intelligence, indicates that in the US, adverse drug reactions are approximated to lead to 200,000 to 400,000 fatalities each year, surpassing the combined mortality from stroke and diabetes. Annually, approximately 2.7 million cases lead to more than 100,000 hospitalizations and over 15,000 deaths. Consequently, the increased occurrence of adverse drug reactions is a primary factor fueling the expansion of the post-marketing pharmacovigilance and medical information market.
Which Segment-Based Categories Are Covered In The Post-Marketing Pharmacovigilance And Medical Information Market?
The post-marketing pharmacovigilance and medical information market covered in this report is segmented –
1) By Type: Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining
2) By Publication Type: Books, Online Media, Journals
3) By End User: Hospitals, Research Organizations, Other End-Users
Subsegments:
1) By Spontaneous Reporting: Consumer Reporting, Healthcare Professional Reporting, Regulatory Authority Reporting, Pharmaceutical Company Reporting, Digital App-Based Reporting
2) By Intensified Adverse Drug Reaction (ADR) Reporting: Hospital-Based Surveillance, Program-Specific Monitoring, Disease-Specific Monitoring, Product-Specific Monitoring, Real-Time Monitoring Systems
3) By Targeted Spontaneous Reporting: Risk Population-Based Reporting, Therapeutic Class-Based Reporting, Adverse Drug Reaction Focused Reporting, Region-Specific Reporting, Healthcare Setting-Specific Reporting
4) By Cohort Event Monitoring: Prospective Cohort Monitoring, Retrospective Cohort Monitoring, Active Follow-Up Monitoring, New Drug User Monitoring, Disease Registry-Linked Monitoring
5) By Electronic Health Record (EHR) Mining: Natural Language Processing-Based Mining, Artificial Intelligence (AI) And Machine Learning Algorithms, Rule-Based Signal Detection, Longitudinal Patient Data Analysis, Integrated Hospital Data Systems
Which Trends Are Influencing The Direction Of The Post-Marketing Pharmacovigilance And Medical Information Market?
Leading companies in the post-marketing pharmacovigilance and medical information market are focusing on developing advanced solutions, such as AI-driven pharmacovigilance processes, to improve the accuracy of adverse event detection and enable real-time safety monitoring for enhanced patient outcomes. AI-powered pharmacovigilance workflows utilize artificial intelligence to automate the oversight of drug safety, leading to faster identification of adverse events and improved regulatory adherence. For instance, in January 2024, PubHive Ltd., a UK-based cloud-software-as-a-service (SaaS) company, introduced a centralized Summary of Product Characteristics (SmPC) management system for life science companies and research organizations. This platform consolidates vital drug safety information into a single, easily accessible repository, automates literature surveillance and regulatory reporting, strengthens team collaboration, and streamlines compliance procedures through advanced AI capabilities. This empowers pharmacovigilance teams to operate more efficiently and proactively, ensuring both patient safety and conformity to regulatory standards.
Which Organizations Are Operating Within The Post-Marketing Pharmacovigilance And Medical Information Market?
Major companies operating in the post-marketing pharmacovigilance and medical information market are Accenture plc, Sanofi S.A., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, ICON plc, Syneos Health Inc., Genpact Limited, Parexel International Corporation, Avalere Health LLC, Quanticate Limited, Inizio Consulting LLC
Access The Complete Post-Marketing Pharmacovigilance And Medical Information Market Report:
Which Regional Market Leads The Post-Marketing Pharmacovigilance And Medical Information Market?
North America was the largest region in the post-marketing pharmacovigilance and medical information market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-marketing pharmacovigilance and medical information market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Post-Marketing Pharmacovigilance And Medical Information Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=27393&type=smp
Browse Through More Reports Similar to the Global Post-Marketing Pharmacovigilance And Medical Information Market 2026, By The Business Research Company
Drain Cleaning Equipment Market Report 2026
https://www.thebusinessresearchcompany.com/report/drain-cleaning-equipment-global-market-report
Urinary Drainage Bags Market Report 2026
https://www.thebusinessresearchcompany.com/report/urinary-drainage-bags-global-market-report
Prefabricated Buildings Market Report 2026
https://www.thebusinessresearchcompany.com/report/prefabricated-buildings-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model